These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17155891)

  • 1. Clots and cancer.
    Ali SN; Stebbing J; Mazhar D
    Future Oncol; 2006 Dec; 2(6):647-9. PubMed ID: 17155891
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of low-molecular-weight heparins in treating thrombosis.
    Lee AY
    J Support Oncol; 2006 Mar; 4(3):123-4. PubMed ID: 16553137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
    Schulman S
    Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
    [No Abstract]   [Full Text] [Related]  

  • 5. Home-treatment of deep vein thrombosis in patients with cancer: quality of life impact of therapies.
    Noble S
    Haematologica; 2005 Nov; 90 Suppl():ELT06. PubMed ID: 16266936
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism.
    Prandoni P
    J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of LMW heparin: information for prescribers. Update: 10 April 2002].
    Agence Française de Sécurité Sanitaire Des Produits de Santé (AFSSAPS)
    J Mal Vasc; 2002 Oct; 27(4):231-3. PubMed ID: 12457130
    [No Abstract]   [Full Text] [Related]  

  • 8. Venous thromboembolism and cancer.
    Bergqvist D; Caprini JA; Dotsenko O; Kakkar AK; Mishra RG; Wakefield TW
    Curr Probl Surg; 2007 Mar; 44(3):157-216. PubMed ID: 17437761
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-molecular-weight herapin.
    Whang PG; Lieberman JR
    J Am Acad Orthop Surg; 2002; 10(5):299-302. PubMed ID: 12374480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin and cancer].
    Lykke J
    Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of venous thrombosis in a cancer patient].
    Lepäntalo A
    Duodecim; 2015; 131(7):637-44. PubMed ID: 26233981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home treatment and secondary prevention of deep vein thrombosis.
    Prandoni P; Mosena L
    Haematologica; 2001 Nov; 86(11 Suppl 2):49-53. PubMed ID: 11926778
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme.
    Hull RD; Pineo GF
    Int Angiol; 1998 Sep; 17(3):131-4. PubMed ID: 9821024
    [No Abstract]   [Full Text] [Related]  

  • 15. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY
    Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis.
    Grande C; Caparro M
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):41-9. PubMed ID: 16360897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Ageno W; Squizzato A
    Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 20. NCCN issues first guidelines for deep vein thrombosis treatment in cancer patients.
    Susman E
    J Natl Cancer Inst; 2006 Apr; 98(8):515. PubMed ID: 16622119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.